Figure 2

TSPAN1 is upregulated in prostate cancer tissue. (A) Real-time PCR analysis of TSPAN1 mRNA from normal and matched prostate cancer tissue from 9 patients obtained from radical prostatectomy. (B) We also analysed 32 benign samples from patients with benign prostate hyperplasia (BPH) and 17 malignant samples from transurothelial resection of the prostate (TURP) samples. (C) Analysis of TSPAN1 protein levels in patients with BPH or prostate cancer by Tissue Microarray (TMA). (D) Representative cores from each TMA. (E) TSPAN1 gene expression levels in prostate tissue from the primary or metastatic site in data published by Grasso et al.33.